Literature DB >> 19446335

Primary human hepatocytes are protected against complement by multiple regulators.

Jarkko Halme1, Michael Sachse, Heiko Vogel, Thomas Giese, Ernst Klar, Michael Kirschfink.   

Abstract

Inflammatory liver disorders are often associated with a potentially tissue damaging complement activation directly at the main site of complement protein synthesis. As hepatocytes may be the primary target of complement attack, we investigated the expression and protective capacity of soluble and membrane-bound complement regulatory proteins in primary human hepatocytes (PHH). Isolated PHHs were analyzed for their basal and cytokine-induced complement regulator expression by cytofluorometry, rtPCR, confocal laser microscopy and ELISA. Susceptibility to complement-mediated cell lysis was investigated with cytotoxicity tests. In contrast to previous reports, PHHs expressed CD46, CD55, CD59, soluble CD59 (sCD59) and factor H (fH), but not CD35. A low basal expression of CD55 was strongly enhanced by IFN-gamma, IL-1 beta and TNF-alpha. The expression of CD59 could be augmented by IL-1 beta, IL-6 and TNF-alpha but was suppressed by IFN-gamma. CD46 expression was not significantly altered. PHHs synthesized fH and sCD59 and fH was detected on PHH surface after exposure to IL-1 beta. Inhibition experiments revealed that CD59 was most effective in protecting PHHs from complement attack. These data clearly indicate that PHHs are protected by multiple complement regulatory proteins, which are controlled by proinflammatory cytokines. CD59 appears to be pivotal in protecting PHHs against complement-mediated lysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446335     DOI: 10.1016/j.molimm.2009.04.005

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

Review 1.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

2.  The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury.

Authors:  Jinyan Zhang; Weiguo Hu; Wei Xing; Tao You; Junming Xu; Xuebin Qin; Zhihai Peng
Journal:  Am J Pathol       Date:  2011-10-19       Impact factor: 4.307

3.  Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.

Authors:  Budhaditya Mazumdar; Hangeun Kim; Keith Meyer; Sandip K Bose; Adrian M Di Bisceglie; Ratna B Ray; Michael S Diamond; John P Atkinson; Ranjit Ray
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

Review 4.  Redox signaling and the innate immune system in alcoholic liver disease.

Authors:  Jessica I Cohen; Xiaocong Chen; Laura E Nagy
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

5.  Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.

Authors:  Z Wang; J Liao; S Wu; C Li; J Fan; Z Peng
Journal:  Cancer Gene Ther       Date:  2016-05-13       Impact factor: 5.987

6.  Complement factor H gene (CFH) polymorphisms C-257T, G257A and haplotypes are associated with protection against severe dengue phenotype, possible related with high CFH expression.

Authors:  André F Pastor; Laís Rodrigues Moura; José W D Neto; Eduardo J M Nascimento; Carlos E Calzavara-Silva; Ana Lisa V Gomes; Ana Maria da Silva; Marli T Cordeiro; Ulisses Braga-Neto; Sergio Crovella; Laura H V G Gil; Ernesto T A Marques; Bartolomeu Acioli-Santos
Journal:  Hum Immunol       Date:  2013-06-06       Impact factor: 2.850

7.  Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.

Authors:  Zhidan Tu; Qing Li; Hong-Shiue Chou; Ching-Chuang Hsieh; Howard Meyerson; Marion G Peters; Hong Bu; John J Fung; Shiguang Qian; Lina Lu; Feng Lin
Journal:  Immunobiology       Date:  2010-08-19       Impact factor: 3.144

8.  Telbivudine treatment corrects HBV-induced epigenetic alterations in liver cells of patients with chronic hepatitis B.

Authors:  Yi Tian; Dongjing Ni; Weibing Yang; Yi Zhang; Keji Zhao; Jianxun Song; Qing Mao; Zhiqiang Tian; Jennifer C van Velkinburgh; Di Yang; Yuzhang Wu; Bing Ni
Journal:  Carcinogenesis       Date:  2013-09-25       Impact factor: 4.944

9.  Triggering of the dsRNA sensors TLR3, MDA5, and RIG-I induces CD55 expression in synovial fibroblasts.

Authors:  Olga N Karpus; Kirstin M Heutinck; Paul J M Wijnker; Paul P Tak; Jörg Hamann
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

10.  Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus.

Authors:  Asim Ejaz; Eike Steinmann; Zoltán Bánki; Sana Khalid; Susanne Lengauer; Corinne Wilhelm; Heinz Zoller; Anna Schloegl; Joerg Steinmann; Elena Grabski; Michael Kleines; Thomas Pietschmann; Heribert Stoiber
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.